| Metric | FY 2020 | Prior Q | FY 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $17M | — | $40M | — | -56.7% |
| Op. Income | $25M | — | $39M | — | -34.8% |
| Gross Margin | 93.9% | — | 100.0% | — | -6.1pp |
| Net Margin | 88.7% | — | 97.7% | — | -8.9pp |
| EPS (Diluted) | $0.76 | — | $1.93 | — | -60.6% |
| Free Cash Flow | $26M | — | $19M | — | 36.3% |
| Item | Amount |
|---|---|
| REVENUE | $17M |
| Cost of Revenue | $1M |
| GROSS PROFIT | $16M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $889.0K |
| SG&A Expenses | $889.0K |
| Other Expenses | $0 |
| Operating Expenses | $889.0K |
| Cost & Expenses | $5M |
| OPERATING INCOME | $25M |
| Interest Income | $29M |
| Interest Expense | $1M |
| Other Income/Expenses | -$10M |
| INCOME BEFORE TAX | $15M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | -$25M |
| EBIT | $25M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $17M |
| Cost of Revenue | $1M |
| GROSS PROFIT | $16M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $889.0K |
| SG&A Expenses | $889.0K |
| Other Expenses | $0 |
| Operating Expenses | $889.0K |
| Cost & Expenses | $5M |
| OPERATING INCOME | $25M |
| Interest Income | $29M |
| Interest Expense | $1M |
| Other Income/Expenses | -$10M |
| INCOME BEFORE TAX | $15M |
| Income Tax Expense | $0 |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $15M |
| D&A | -$25M |
| EBIT | $25M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $15M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $11M |
| Change in Working Capital | -$744.1K |
| OPERATING CASH FLOW | $26M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$21M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$20M |
| FREE CASH FLOW | $26M |
| Net Change in Cash | $6M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $30M |
| Short-Term Investments | $0 |
| Net Receivables | $2M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $32M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $309M |
| Tax Assets | $0 |
| Other Non-Current Assets | $2M |
| TOTAL NON-CURRENT ASSETS | $312M |
| TOTAL ASSETS | $344M |
| Account Payables | $3M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $5M |
| TOTAL CURRENT LIABILITIES | $8M |
| Long-Term Debt | $30M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $30M |
| TOTAL LIABILITIES | $39M |
| Common Stock | $20M |
| Additional Paid-In Capital | $273M |
| Retained Earnings | $12M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $305M |
| Minority Interest | $0 |
| TOTAL EQUITY | $305M |
| TOTAL LIABILITIES & EQUITY | $344M |
| Total Debt | $30M |
| Net Debt | $148.4K |
